Bill Text: TX HB165 | 2017-2018 | 85th Legislature | Introduced
Bill Title: Relating to health benefit plan coverage for certain equipment and supplies associated with diabetes treatment.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2017-02-14 - Referred to Insurance [HB165 Detail]
Download: Texas-2017-HB165-Introduced.html
85R1806 PMO-F | ||
By: Raymond | H.B. No. 165 |
|
||
|
||
relating to health benefit plan coverage for certain equipment and | ||
supplies associated with diabetes treatment. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Sections 1358.051(1) and (2), Insurance Code, | ||
are amended to read as follows: | ||
(1) "Diabetes equipment" means: | ||
(A) blood glucose monitors, including | ||
noninvasive glucose monitors and glucose monitors designed to be | ||
used by blind individuals; | ||
(B) insulin pumps and associated supplies and | ||
appurtenances, including insulin pumps that work in conjunction | ||
with another medical device to provide automated or predictive | ||
insulin infusion suspend or control functionality as part of a | ||
system classified as an artificial pancreas device system by the | ||
United States Food and Drug Administration; | ||
(C) insulin infusion devices; [ |
||
(D) podiatric appliances for the prevention of | ||
complications associated with diabetes; and | ||
(E) continuous glucose monitoring devices that | ||
continuously record glucose levels of individual users whether a | ||
freestanding device or integrated into an insulin pump. | ||
(2) "Diabetes supplies" means: | ||
(A) test strips for blood glucose monitors; | ||
(B) visual reading and urine test strips; | ||
(C) lancets and lancet devices; | ||
(D) insulin and insulin analogs; | ||
(E) injection aids; | ||
(F) syringes; | ||
(G) prescriptive and nonprescriptive oral agents | ||
for controlling blood sugar levels; [ |
||
(H) glucagon emergency kits; and | ||
(I) supplies related to insulin pumps and | ||
continuous glucose monitoring devices, including insulin infusion | ||
sets, insulin reservoirs, glucose sensors, and glucose data | ||
transmitters. | ||
SECTION 2. This Act applies only to a health benefit plan | ||
that is delivered, issued for delivery, or renewed on or after | ||
September 1, 2017. A health benefit plan delivered, issued for | ||
delivery, or renewed before September 1, 2017, is governed by the | ||
law as it existed immediately before the effective date of this Act, | ||
and that law is continued in effect for that purpose. | ||
SECTION 3. This Act takes effect September 1, 2017. |